Spinal Muscular Atrophy (SMA) is a common autosomal recessive neurodegenerative disease caused by reduced SMN levels. The assembly machinery containing SMN is implicated in the biogenesis of the spliceosomal small nuclear ribonucleoproteins, snRNPs. SMN is present in both the cytoplasm and nucleus, where it transiently accumulates in subnuclear domains named Cajal bodies (CBs) and functions in the maturation of snRNPs and small nucleolar 
Introduction
Proximal spinal muscular atrophy (SMA) is a progressive degenerative disorder of lower (alpha) motor neurons (1) . It is one of the most common genetic causes of mortality in childhood with an incidence of 1 in 6,000-10,000 newborns. Based on the age of onset and severity, SMA has been classified into three main types that compose a continuum of severe (Type I), intermediate (Type II) and moderate (Type III) forms of disease. SMA is caused by mutations in the survival motor neuron 1 gene (SMN1) that result in reduced levels of the SMN protein (2) (3) (4) . SMN1 possesses a near identical copy, SMN2. The copy number of SMN2 parallels the clinical severity (5) . The functional difference between the two genes lies on a translational silent single nucleotide in exon 7 that generates the SMN2-specific alternative splicing of exon 7 (2, (6) (7) (8) (9) . The removal of exon 7 from SMN2 transcript results in the replacement of the C-terminal 16 amino acid (aa) residues of SMN by 4-aa sequence (SMNΔex7) that might affect the stability of the truncated protein (6, 10) . SMN1 produces much more of the transcript encoding the full-length SMN than SMN2 gene, while the main transcript of SMN2 encodes SMNΔex7. Together these data identify SMN2 as a major modifier gene. Genetically engineered animal models of SMA confirm that SMN is a vital protein (11) (12) and SMN2 gene products can partially compensate for the inactivation of 4 (22-23) and together are imported to the nucleus (24). The newly imported snRNPs transiently accumulate in SMN-containing Cajal bodies (CBs) for their maturation into the fully assembled splicing snRNPs (25, 26).
CBs are defined as subnuclear bodies that concentrate the CB marker protein coilin (27). They contain several functionally distinct categories of components that are involved in RNA metabolism, such as factors implicated in the maturation of the telomerase RNP and in pre-ribosomal RNA processing, as well as snRNPs and small nucleolar (sno)RNPs. CBs are also involved in the complex intranuclear trafficking of those RNPs (28, 29). Interestingly, SMN interacts directly with the core snoRNP components fibrillarin and GAR1, raising the possiblity that SMN might also be involved in the late snoRNP assembly step in CBs (30, 31).
Similar to snRNPs, box C/D snoRNPs transiently localise in CBs before ending up in the nucleolus (32, 33). It has been proposed that PHAX (phosphorylated adaptor for RNA export) recruits the snoRNP precursors to CBs and CRM1 (chromosome region maintenance 1) targets the mature snoRNPs to the nucleolus (34). The presence of CRM1 in CBs might also be related to the retention of newly imported snRNPs into CBs (35). We have previously reported that snRNPs are not detected in CBs of fibroblast cells from all three types of SMA (36), suggesting that other CB constituents could also be absent.
In this study we analysed the sub-nuclear localisation of other CB components to address the consequences of reduced SMN levels in fibroblast cells derived from SMA patients. Interestingly, the presence of the snoRNP chaperone Nopp140 in CBs from fibroblast cells was correlated with the SMA disease severity. The relationship between SMN and Nopp140 was further assayed using RNAi to deplete immortalised control fibroblast cells of SMN or Nopp140. The immunofluorescence analyses showed that no localisation of Nopp140 is observed in residual CBs of SMN-depleted fibroblast cells. The depletion of Nopp140 slightly reduced the localisation of SMN in CBs. In SMA Type I-derived fibroblast
Results

Nopp140 is barely detectable in CBs of SMA-derived fibroblast cells
To assess the composition of CBs in SMA cells, immortalised Type I SMA-derived fibroblasts (from here on simply referred to as SMA cells) were further subjected to immunofluorescence analyses with antibodies against proteins that transiently accumulate in CBs, subnuclear structures involved in non-coding RNA maturation. Antibodies specific for the CB marker coilin were used to visualise CBs. We first examined the distribution of CRM1 and PHAX that are part of the U snRNA export complex (29) and that are also intranuclear transport factors for snoRNAs (34, 37). CRM1 and PHAX were shown here to distribute in the nucleoplasm and colocalised with the CB marker coilin in CBs in both SMA and control cells (Fig. 1) . The statistical analyses of the double-immunolabelling studies revealed that CBs accumulated CRM1 in 23% and 11% of SMA and control cells, respectively ( Fig. 1A ; Table 1 ). PHAX foci showed complete localisation in CBs in 14% of SMA and in 21% of control cells (Fig. 1B, Table 1 ). We previously showed that SMN accumulates in CBs in about 6% of SMA compared to 64% of control cells (36). Together these results indicated that the retention of CRM1 and PHAX in CBs appears independent of the presence of SMN.
We also examined the distribution of fibrillarin, GAR1, NAP57/dyskerin and Nopp140, nuclear proteins associated with snoRNPs that are shared between the nucleoli and CBs. Fibrillarin is a core protein associated with the C/D box snoRNPs, such as U3 snoRNPs (29). GAR1 and NAP57/dyskerin are H/ACA box snoRNP core proteins (38) . Moreover, SMN has been shown to interact directly with fibrillarin and GAR1 (30, 31), but was not found associated with the mature snoRNPs (37) . Nopp140 is a snoRNP chaperone that transiently associates with the mature nucleolar H/ACA and C/D box snoRNPs (38) . In addition, Nopp140 has been shown to bind directly to the CB marker coilin (39) . First, the nucleolar distribution of those proteins appeared similar in SMA and control cells (Fig. 1C-F) .
Double immunolabelling experiments showed that in 17% of SMA cells fibrillarin accumulated with coilin in CBs as compared to 37% of control cells ( Fig. 1C ; Table 1 ). In the remainder of cells the CBs did not contain fibrillarin. GAR1 localised with coilin in CBs from 6% of SMA and 23% of control cells and NAP57/dyskerin in CBs from 5% of SMA and 36% of control cells (Fig. 1D-E In summary, our results revealed that PHAX, CRM1 and fibrillarin are associated with CBs in similar proportion (14-23%) of SMA cells ( Table 1) . The H/ACA core snoRNP proteins GAR1 and NAP57/dyskerin showed a marked reduction of CB localisation in SMA compared to control cells. In addition, Nopp140 was only occasionally associated with CBs and rather accumulated in residual nuclear bodies.
CBs actively recruit Nopp140 in cells over-expressing SMN
Because SMN levels are markedly reduced in SMA cells (41), we tested whether SMN levels might play a role in the localization of Nopp140 to CBs. Therefore, the SMA fibroblast cells were transiently transfected with the expression vector encoding eGFP-SMN and were analysed with antibodies against Nopp140 (Fig. 3) . We previously showed that eGFP-SMN concentrates in CBs of transfected cells (36). Cells over-expressing the transgene showed Nopp140 and eGFP-SMN colocalise in CBs from 34% of transfected cells, which is similar to the proportion of control fibroblasts (35%, Table 1 ). These data confirmed that increased SMN levels contribute to the localisation of Nopp140 in CBs.
RNAi knockdown experiments confirm a functional link between Nopp140 and SMN
To further investigate the relationship between Nopp140 and SMN, we used RNAi-mediated depletion of SMN or of Nopp140 in control fibroblasts (Fig. 4A-C 
SMA mutant proteins fail to enhance the CB localisation of Nopp140
Because our results favoured the view that SMN levels are important for Nopp140
localisation to CBs, we tested the effects of eGFP-SMN over-expression in COS cells, which already expressed high amount of endogenous SMN (Fig. 5A-C 
The disease severity correlates with the CB localisation of Nopp140
Previous immunofluorescence studies showed that SMA disease severity correlates with the number of fibroblasts with SMN foci (4, 36). A similar correlation was established with the localisation of SMN in CBs from motor neurons of spinal cord sections from SMA foetuses (3). These observation along with the reduced accumulation of Nopp140 in CBs from SMA fibroblasts, prompted us to examine the potential relationship between Nopp140 and SMA severity. Therefore, we analysed primary cultures of skin fibroblasts from all three Types of SMA patients (Fig. 6, Table 2 ). Double labelling for Nopp140 and the CB marker coilin revealed that Nopp140 localised in CBs of 63% CB-containing cells from a control infant (Fig. 6C, Table 2 ). Nopp140 accumulated in CBs of about 20, 40 and 65% of CB-containing cells obtained from Type I, II or III SMA patients, respectively (Fig. 6C, Table 2 ). These results revealed a correlation between disease severity and altered composition of CBs in fibroblasts from SMA patients.
Discussion
We have analysed here the localisation of a number of protein constituents of CBs in fibroblast cells derived from infants affected with SMA. We show that the disease severity inversely correlates with the number of cells containing the snoRNP chaperone Nopp140-positive CBs. Moreover, the functional deficiency of the SMA mutant proteins in transiently transfected COS cells is reflected by their failure to stimulate the accumulation of Nopp140 in CBs.
The low levels of SMN in SMA-derived fibroblasts, that prevents the accumulation of snRNPs in CBs (36), does not impair the CB localisation of two factors that are implicated in the spliceosomal U snRNA export from the nucleus (42), PHAX and CRM1 (Table 1) . We observe here an increased localisation of CRM1 in CBs of SMA cells. This might reflect a change in its intranuclear trafficking and/or in its nucleocytoplasmic transport. Indeed, the newly synthesized U1, U2, U4 and U5 snRNAs are initially exported to the cytoplasm where they are assembled into pre-mature snRNPs by the SMN complex (26, 29). The U snRNA nuclear export requires a monomethyl cap structure on the RNA for the association with the nuclear cap-binding complex (CBC). The adaptor PHAX binds both CBC and U snRNA forming the pre-complex that interacts with the NES (nuclear export signal) receptor CRM1 for the translocation into the cytoplasm. Our results are consistent with the observation that the levels of the most abundant snRNPs are unchanged in SMA fibroblasts (43) . However, depletion of SMN in SMA mouse models affects the nuclear accumulation of snRNPs in motor neurons (44) and the repertoire of snRNAs (43, 45) and the quality of splicing in a tissues-specific manner (45).
Interestingly, PHAX was shown to be involved in the complex intra-nuclear trafficking of snoRNAs that guide post-transcriptional modifications of ribosomal rRNAs and spliceosomal snRNAs (46) . Indeed, the accumulation of the precursor U3 box C/D snoRNA in CBs requires the interaction with PHAX. In CBs, the precursor snoRNA assembles with box C/D core proteins Nop56, Nop58 and fibrillarin and the 3' end is subjected to modifications prior that the mature snoRNP is targeted to the nucleolus by CRM1 (34). SMN has been shown to interact with fibrillarin (30, 31), but was not found associated with functional snoRNPs, suggesting that SMN might be involved in a late assembly step (37) .
Nevertheless, the accumulation of the U3 snoRNA depends on SMN levels (37) Nopp140, the mammalian ortholog of Srp40p, is an abundant phosphoprotein detected predominantly in nucleoli and is among the first proteins that have been identified in CBs (48, 49) . Nopp140 associates with the functional H/ACA snoRNP particles that are formed of a H/ACA RNA and four core proteins, NAP57/dyskerin, GAR1, NHP2 and NOP10 (50) . It has been shown that SMN binds directly to GAR1 (30), which is not essential for the structural intergrity of H/ACA RNPs (38) . Among the different types of H/ACA RNAs there are the small CB specific RNAs (scaRNA), which form the scaRNPs that guide snRNA modifications in CBs (33). In this regard, it will be interesting to analyse in a future study the RNA composition of CBs in SMA cells.
Nopp140 is not an integral part of snoRNPs and the association occurs through simultaneous interactions of Nopp140 with several components of the assembled snoRNPs (38) . Nopp140 also associates with precursor and mature box C/D snoRNPs in the nucleoplam and not with the functional snoRNPs in the nucleolus, indicating that Nopp140 acts during the final maturation steps before the localization of box C/D snoRNPs in nucleoli (37) . Therefore, Nopp140 appears as chaperone of both box H/ACA and box C/D RNPs (38).
Our analyses here reveal that Nopp140 localisation in nucleoli is unaffected in fibroblasts from all three forms of SMA patients. However, the localisation of Nopp140 in CBs is altered in primary SMA cells and shows a correlation with disease severity. This is even more surprising given that Nopp140 has been shown to interact directly with coilin (39) and that the Nopp140-binding domain of coilin plays a role in the dynamic retention of coilin in CBs (51).
We were able to restore the accumulation of Nopp140 in (Table 1 ). This finding may indicate a tighter association of Nopp140 with H/ACA RNPs whose major core protein NAP57/dyskerin was originally identified as being Nopp140-associated (48) . It is also possible that the presence of Nopp140 in CBs is associated with a novel function of CBs that remains to be identified.
The localisation of maturation factors in CBs is important for RNP biogenesis (28).
Recent reports show that during their biogenesis, RNPs undergo remodelling that requires a complex interplay of transient interactions with a processing machinery (57) . The role of the Hsp90 chaperone in the biogenesis of U3 box C/D snoRNP, U4 snRNA and the telomerase box H/ACA scaRNP exemplifies this (58) . It remains to be established whether this remodelling machinery requires SMN and Nopp140 to function.
Materials and methods
Cell culture and transfections
Human fibroblasts and COS cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% foetal bovine serum (FBS), penicillin (100U/ml) and streptomycin (100 mg/ml). Cells were plated in either 60-mm or eight-chamber culture-slides (Becton Dickson Lab) and transiently transfected with purified DNA plasmids using either 
Cell fixation and immunofluorescence microscopy
Cells were fixed for 20 min in freshly made PBS/4% paraformaldehyde and permeabilized for 10 min with 1% Triton X-100 in PBS at room temperature. After three washes, the samples were blocked with 10% horse serum (HS) in PBS for 1 h and then, incubated with primary antibodies diluted in 1% HS as described in Table 3 
Cell lysate preparation and immunoblotting
The cells were detached from culture flasks in ice-cold PBS using cell scraper, washed once in the same buffer and centrifuged at 500 x g for 5 min in a refrigerated bench centrifuge (Eppendorf 5417R) as previously described (34). The cellular pellets were either keept frozen at -80°C or immediately proceeded for immunoblotting analyses. The pellets were resuspended in ice-cold Tris-HCl buffer (25 mM, pH 7.4) in the presence of EDTA-free protein inhibitors (Roche). Following a Bradford assay (Bio-Rad Laboratories) using BSA as standard, the protein extracts were diluted in Laemmli sample buffer, separated by SDS-PAGE using Prosieve polyacrylamide (FMC BioProducts) and electrotransferred onto Immobilon-P membranes (PVDF, Millipore). The membranes were incubated with primary antibodies diluted in 5% non-fat milk in PBS for overnight at 4°C and proceed with horseradish peroxidase-conjugated secondary antibody (1:10000) and detected using chemiluminescent reagents (General Electric). The dilution of the antibodies used was as follows: anti-SMN (1:1000 from Transduction Laboratories), anti-Nopp140 (RS8, 1:5000, 59) and anti-α-tubulin (1:10,000 from Sigma-Aldrich). The X-ray films were scanned as a grayscale image at medium resolution (300-400 dpi) and the relative quantitation of knockdown proteins was determined using the gel analysis method from ImageJ. b, CBs were visualised using anti-coilin antibodies.
The values of Type I and II primary skin fibroblasts were statistically different from control cells (Pχ2≤0.001). 
